Integrated early Altasciences offers a one-stop solution for early-phase drug development, presenting a compelling cross-sell to sponsors seeking to streamline CRO/CDMO partnerships and reduce vendor management complexity.

Strategic partnerships Recent collaborations with Evidence Matters, Certara, VoxCell BioInnovation, and EcoVadis indicate a proactive expansion into data science, model-informed development, advanced tissue testing, and ESG commitments—opportunities to position Altasciences as a preferred partner for integrated programs.

Growth and leadership Stable leadership with a track record of transformation and multi-location North American presence signals reliability for large sponsors seeking scale, geographic reach, and consistent program execution across sites.

Awarded credibility Industry recognition, including the 2025 CDMO Leadership Award in Small Molecule Dosage Form, enhances credibility with potential clients and can be leveraged in outbound messaging to win early-phase programs.

Financial scale With reported revenue in the hundreds of millions and a sizable employee base, Altasciences offers a credible partner for mid- to large-scale early-phase programs, suggesting upsell paths into broader services such as clinical pharmacology, manufacturing, and data management.